Detected nitrosamine-group impurities (NDMA and NDEA) in the active substance losartan potassium, which may affect human health and life, even though the levels do not exceed acceptable limits. Potential effects: possible carcinogenic effects and health complications with long-term use.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use products containing losartan potassium from the contaminated series/manufacturer; verify batch information at the pharmacy or with your doctor; if in doubt, consult a physician to select an...
The Chief Pharmaceutical Inspector decided to withdraw from the market medicinal products containing losartan potassium contaminated with NDMA and NDEA and granted the decision immediate enforceabilit...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related